Skip to main content
. 2010 Nov;51(11):5646–5656. doi: 10.1167/iovs.10-5523

Figure 9.

Figure 9.

Morphometric analysis of frequency of BrdU-positive cells at (A) 1 and (B) 2 weeks in the recessed SR, the antagonist IR, and the contralateral SR compared with the frequency in normal control superior rectus muscles. *Significantly different from the control. Data are expressed as the mean ± SEM.

HHS Vulnerability Disclosure